Small interfering RNA targeting NF-κB attenuates lipopolysaccharide-induced acute lung injury in rats

BMC Physiol. 2016 Dec 28;16(1):7. doi: 10.1186/s12899-016-0027-y.

Abstract

Background: To investigate the anti-inflammatory effects of specific small interfering RNA targeting NF-κB on lipopolysaccharide (LPS)-induced acute lung injury (ALI) in rats.

Method: Acute lung injury was induced in Sprague-Dawley rats by intraperitoneal injection with LPS (5 mg/kg), followed by immediate intratracheal instillation of siRNA targeting NF-κB p65 (40 μg/ml). Animals in each group were sacrificed at 1 h or 8 h after the instillation. Pulmonary histological changes were evaluated by hematoxylin-eosin staining. The levels of NF-κB and TNF-α were measured by qRT-PCR. Expressions of NF-κB in lung cells and TNF-α in bronchoalveolar lavage fluid (BALF) were determined by western blot analysis and enzyme-linked immunosorbent assay (ELISA) respectively.

Results: LPS administration reduced the rectal temperature and white blood cell counts at 1 h, increased lung wet/dry weight ratios, caused evident lung histopathological injury, and increased the detectable transcript and cytokine levels of TNF-α in lung tissue in BALF. siRNA targeting of NF-κB p65 effectively abrogated the expression of NF-κB p65 in lung cells and, aside from rectal temperatures, ameliorated all changes induced by LPS.

Conclusions: NF-κB knockdown exerts anti-inflammatory effects on LPS-induced ALI especially in the initial phase, which may be due in part to reduced levels of the proinflammatory cytokine TNF-α. NF-κB siRNA's rapidity and effectiveness to abrogate ALI development may provide an effective therapeutic method with future clinical applications.

Keywords: Acute lung injury; Lipopolysaccharide; Nuclear factor-κB; RNA interference.

MeSH terms

  • Acute Lung Injury / chemically induced
  • Acute Lung Injury / complications
  • Acute Lung Injury / metabolism*
  • Acute Lung Injury / pathology*
  • Animals
  • Body Temperature / drug effects
  • Bronchoalveolar Lavage Fluid / chemistry
  • Cell Count
  • Leukocytes / drug effects
  • Lipopolysaccharides
  • NF-kappa B / antagonists & inhibitors*
  • NF-kappa B / metabolism
  • Pneumonia / chemically induced
  • Pneumonia / complications
  • Pneumonia / metabolism*
  • Pneumonia / pathology*
  • RNA, Small Interfering / administration & dosage*
  • Rats
  • Rats, Sprague-Dawley
  • Tumor Necrosis Factor-alpha / metabolism

Substances

  • Lipopolysaccharides
  • NF-kappa B
  • RNA, Small Interfering
  • Tumor Necrosis Factor-alpha